The present cross-sectional study demonstrated increased serum RBP4 levels in patients with CAD (either AMI or SA) compared to age- and sex-matched individuals without CAD, but with at least 2 classical cardiovascular risk factors. The gene discussed is RBP4; the disease is coronary artery disorder.